Role of ischemic blood-brain barrier on amyloid plaques development in Alzheimer's disease brain

Current Neurovascular Research

Volumn 4, Issue 2, 2007, Pages 121-129

  Pluta, Ryszard ^a  

^a MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

amyloid peptide; Alzheimer's disease; Amyloid plaques; Blood brain barrier; Brain ischemia; Gray and white matter lesions; Horseradish peroxidase; Leukoaraiosis; Leukocytes; Platelets

Indexed keywords

ALPHA SECRETASE; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; GAMMA SECRETASE; GELSOLIN; HORSERADISH PEROXIDASE; MYELIN;

ALZHEIMER DISEASE; ANGIOGENESIS; BLOOD BRAIN BARRIER; BLOOD COMPONENT; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL MEMBRANE PERMEABILITY; CHRONIC DISEASE; DISEASE COURSE; GRAY MATTER; HUMAN; LEUKOCYTE; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN METABOLISM; REVIEW; THROMBOCYTE; VASOCONSTRICTION; WHITE MATTER;

ALZHEIMER DISEASE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN; BRAIN ISCHEMIA; HUMANS; SENILE PLAQUES;

EID: 34248181862     PISSN: 15672026     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720207780637207     Document Type: Review

References (103)

1. Anfuso, CD, Assero, G, Lupo, G, Nicota, A, Cannavo, G, Strosznajder, RP, Rapisarda, P, Pluta, R, Alberghina, M. (2004) Amyloid beta (1-42) and its beta (25-35) fragment induce activation and membrane translocation of cytosolic phospholipase A (2) in bovine retina capillary pericytes. Biochem Biophys Acta 1686: 125-138.
2. Armstrong, RA. (2006) Plaques and tangles and the pathogenesis of Alzheimer's disease. Folia Neuropathol 44: 1-11.
3. Attems, J, Jellinger, KA. (2004) Only cerebral capillary amyloid angiopathy correlates with Alzheimer pathology - a pilot study. Acta Neuropathol 107: 83-90.
4. Attems, J, Lintner, F, Jellinger, KA. (2004) Amyloid β peptide 1-42 highly correlates with capillary cerebral amyloid angiopathy and Alzheimer disease pathology. Acta Neuropathol 107: 283-291.
5. Atwood, CS, Obrenovich, ME, Liu, T, Chan, H, Perry, G, Smith, MA, Martins, RN. (2003a) Amyloid-beta: a chameleon walking in two worlds: a review of the trophic and toxic properties of amyloid-β. Brain Res Brain Res Rev 43: 1-16.
6. Atwood, CS, Bowen, RL, Smith, MA, Perry, G. (2003b) Cerebrovascular requirement for sealant, anti-coagulant and remodeling molecules that allow for the maintenance of vascular integrity and blood supply. Brain Res Brain Res Rev 43: 164-178.
7. Badan, I, Dinca, I, Buchhold, B, Suofu, Y, Walker, L, Gratz, M, Platt, D, Kessler, CH, Popa-Wagner, A. (2004) Accelerated accumulation of N-and C-terminal beta APP fragments and delayed recovery of microtubule-associated protein 1B expression following stroke in aged rats. Eur J Neurosci 19: 2270-2280.
8. Bailey, TL, Rivara, CB, Rocher, AB, Hof, PR. (2004) The nature and effects of cortical microvascular pathology in aging and Alzheimer's disease. Neurol Res 26: 573-578.
9. Bales, KR, Tzavara, ET, Wu, S, Wade, MR, Bymaster, FP, Paul, SM, Nomikos, GG. (2006) Cholinergic dysfunction in a mouse model of Alzheimer disease is reversed by an anti-Aβ antibody. J Clin Invest 116: 825-832.
10. Bennett, DA, Wilson, RS, Schneider, JA, Evans, DA, Mendes de Leon, CF, Arnold, SE, Barness, LL, Bienias, JL. (2003) Education modifies the relation of AD pathology to level of cognitive function in older persons. Neurology 60: 1909-1915.
11. Bergamaschini, L, Rossi, E, Storini, C, Pizzimenti, S, Distaso, M, Pergo, C, De Luigi, A, Vergani, C, De Simoni, MG. (2004) Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and beta-amyloid accumulation in a mouse model of Alzheimer's disease. J Neurosci 24: 4181-4186.
12. Blanc, EM, Toborek, M, Mark, RJ, Hennig, B, Mattson, MP. (1997) Amyloid β-peptide induces cell monolayer albumin permeability, impairs glucose transport, and induces apoptosis in vascular endothelial cells. J Neurochem 68: 1870-1881.
13. Caceres, MJ, Schleien, CL, Kuluz, JW, Gelman, B, Dietrich, WD. (1995) Early endothelial damage and leukocyte accumulation in piglet brains following cardiac arrest. Acta Neuropathol 90: 582-591.
14. Carmeliet, P. (2003) Angiogenesis in health and disease. Nat Med 9: 653-660.
15. Deane, R, Du Yan, S, Submamaryan, RK, LaRue, B, Jovanovic, S, Hogg, E, Welch, D, Manness, L, Lin, C, Yu, J, Zhu, H, Ghiso, J, Frangione, B, Stern, A, Schmidt, AM, Armstrong, DL, Arnold, B, Liliensiek, B, Nawroth, P, Hofman, F, Kindy, M, Stern, D, Zlokovic, BV. (2003) RAGE mediates amyloid-β peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9: 907-913.
16. Deane, R, Wu, Z, Sagare, A, Davis, J, Du Yan, S, Hamm, K, Xu, F, Parisi, M, LaRue, B, Hu, HW, Spijkers, P, Guo, H, Song, X, Lenting, PJ, Van Nostrand, WE, Zlokovic, BV. (2004) LRP/amyloid β-peptide interaction mediates differential brain efflux of Aβ isoforms. Neuron 43: 333-344.
17. Deane, R, Sagare, A, Hamm, K, Parisi, M, LaRue, B, Guo, H, Wu, Z, Holtzman, DM, Zlokovic, BV. (2005) IgG-assisted age-dependent clearance of Alzheimer's amyloid beta peptide by the blood-brain barrier neonatal Fc receptor. J Neurosci 25: 11495-11503.
18. DeMattos, RB, Bales, KR, Cummins, DJ, Paul, SM, Holtzman, DM. (2002) Brain to plasma amyloid-β efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295: 2264-2267.
19. DeMattos, RB, Bales, KR, Cummins, DJ, Dodart, JC, Paul, SM, Holtzman, DM. (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decrease brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98: 8850-8855.
20. Dickstein, DL, Biron, KE, Ujiie, M, Pfeifer, CG, Jeffries, AR, Jefferies, WA. (2006) Aβ peptide immunization restores blood-brain barrier integrity in Alzheimer disease. FASEB J 20: 426-433.
21. Duyckaerts, C. (2004) Looking for the link between plaques and tangles. Neurobiol Aging 25: 735-739.
22. Eckman, EA, Watson, M, Marlow, L, Sambamurti, K, Eckman, CB. (2003) Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278: 2081-2084.
23. Eckman, EA, Eckman, CB. (2005) Abeta-degrading enzymes: modulators of Alzheimer's disease pathogenesis and targets for therapeutic intervention. Biochem Soc Trans 33: 1101-1105.
24. Farkas, IG, Czigner, A, Farkas, E, Dobo, E, Soos, K, Penke, B, Endresz, V, Mihaly, A. (2003) Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain. Acta Histochem 105: 115-125.
25. Ferrer, I, Boada Rovira, M, Sanchez Guerra, ML, Rey, MJ, Costa-Jussa, F. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol 14: 11-20.
26. Gartshore, G, Patterson, J, Macrae, IM. (1997) Influence of ischemia and reperfusion on the course of brain tissue swelling and blood-brain barrier permeability in a rodent model of transient focal cerebral ischemia. Exp Neurol 147: 353-360.
27. Gidday, JM, Gasche, YG, Copin, JC, Shah, AR, Perez, RS, Shapiro, SD, Chan, PH, Park, T.S. (2005) Leukocyte-derived matrix metalloproteinase-9 mediates blood-brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia. Am J Physiol Heart Circ Physiol 289: H558-H568.
28. Gold, G, Bouras, C, Kovari, E, Canuto, A, Glaria, BG, Malky, A, Hof, PR, Michel, JP, Giannakopoulos, P. (2000) Clinical validity of Braak neuropathological staging in the oldest-old. Acta Neuropathol 99: 579-582.
29. Grammas, P. (2000) A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging 21: 199-205.
30. Haan, J, Algra, PR, Roos, RA. (1990) Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases. Arch Neurol 47: 649-653.
31. Haglund, M, Sjobeck, M, Englund, E. (2004) Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia. Dement Geriatr Cogn Disord 18: 132-137.
32. Hayflick, L. (2000) The illusion of cell immortality. Br J Cancer 83: 841-846.
33. Hemming, ML, Selkoe, DJ. (2005) Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor. J Biol Chem 280: 37644-37650.
34. Herz, J. (2003) LRP: a bright beacon at the blood-brain barrier. J Clin Invest 112: 1483-1485.
35. Huber, JD, Egleton, RD, Davis, TP. (2001) Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719-725.
36. Humpel, C, Marksteiner, J. (2005) Cerebrovascular damage as a cause for Alzheimer's disease. Curr Neurovasc Res 2: 341-347.
37. Ishikawa, M, Cooper, D, Arumugam, TV, Zhang, JH, Nanda, A, Granger, DN. (2004) Platelet-leukocyte-endothelial cell interactions after middle cerebral artery occlusion and reperfusion. J Cereb Blood Flow Metab 24: 907-915.
38. Ishimaru, H, Ishikawa, K, Haga, S, Shoji, M, Ohe, Y, Haga, C, Sasaki, A, Takashashi, A, Maruyama, Y. (1996) Accumulation of apolipoprotein E and β-amyloid-like protein in a trace of the hippocampal CA1 pyramidal cell layer after ischaemic delayed neuronal death. Neuroreport 7: 3063-3067.
39. Iwasaki, K, Egashira, N, Hatip-Al-Khatib, I, Akiyoshi, Y, Arai, T, Takagaki, Y, Watanabe, T, Mishima, K, Fujiwara, M. (2006) Cerebral ischemia combined with beta-amyloid impairs spatial memory in the eight-arm radial maze task in rats. Brain Res 1097: 216-223.
40. Iwata, N, Tsubuki, S, Takaki, Y, Shirotani, K, Lu, B, Gerard, NP, Gerard, C, Hama, E, Lee, HJ, Saido, TC. (2001) Metabolic regulation of brain A?? by neprilysin. Science 292: 1550-1552.
41. Jendroska, K, Poewe, W, Daniel, SE, Pluess, J, Iwerssen-Schmidt, H, Paulsen, J, Barthel, S, Schelosky, L, Cervos-Navarro, J, DeArmond, SJ. (1995) Ischemic stress induces deposition of amyloid beta immunoreactivity in human brain. Acta Neuropathol 90: 461-466.
42. Kalaria, RN. (1999) The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease. Ann NY Acad Sci 893: 113-125.
43. Kalaria, RN. (2000) The role of cerebral ischemia in Alzheimer's disease. Neurobiol Aging 21: 321-330.
44. Kalaria, RN. (2002) Small vessel disease and Alzheimer's dementia: Pathological considerations. Cerebrovasc Dis 13(Suppl. 2): 48-52.
45. Kanemitsu, H, Tomiyama, T, Mori, H. (2003) Human neprilysin is capable of degrading amyloid beta peptide not only in the monomeric form but also the pathological oligomeric form. Neurosci Lett 350: 113-116.
46. Kawai, M, Kalaria, RN, Harik, SI, Perry, G. (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer's disease. Am J Pathol 137: 1435-1446.
47. Kida, E, Pluta, R, Lossinsky, AS, Golabek, AA, Choi-Miura, NH, Wisniewski, HM, Mossakowski, MJ. (1995) Complete cerebral ischemia with short-term survival in rat induced by cardiac arrest. II. Extracellular and intracellular accumulation of apolipoproteins E and J in the brain. Brain Res 674: 341-346.
48. Koistinaho, M, Kettunen, MI, Goldsteins, G, Keinanen, R, Salminen, A, Ort, M, Bures, J, Liu, D, Kauppinen, RA, Higgins, LS, Koistinaho, J. (2002) Beta-amyloid precursor protein transgenic mice that harbor diffuse A beta deposits but do not form plaques show increased ischemic vulnerability: role of inflammation. Proc Natl Acad Sci USA 99: 1610-1615.
49. Koistinaho, M, Lin, S, Wu, X, Esterman, M, Koger, D, Hanson, J, Higgs, R, Liu, F, Malkani, S, Bales, KR, Paul, SM. (2004) Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides. Nat Med 10: 719-726.
50. Lam, FC, Liu, R, Lu, P, Shapiro, AB, Renoir, JM, Sharoni, FJ, Reiner, PB. (2001) Beta-amyloid efflux mediated by p-glycoprotein. J Neurochem 76: 1121-1128.
51. Leissring, MA, Farris, W, Chang, AY, Walsh, DM, Wu, X, Sun, X, Frosch, MP, Selkoe, DJ. (2003) Enhanced proteolysis of beta-amyloid in APP transgenic mice prevents plaque formation, secondary pathology, and premature death. Neuron 40: 1087-1093.
52. Louissaint, AJr, Rao, S, Leventhal, C, Goldman, SA. (2002) Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 34: 945-960.
53. Lupo, G, Anfuso, CD, Assero, G, Strosznajder, RP, Walski, M, Pluta, R, Alberghina, M. (2001) Amyloid β (1-42) and its β (25-35) fragment induce in vitro phosphatidylcholine hydrolysis in bovine retina capillary pericytes. Neurosci Lett 303: 185-188.
54. Malm, TM, Koistinaho, M, Parepalo, M, Vatanen, T, Ooka, A, Karlsson, S, Koistinaho, J. (2005) Bone-marrow-derived cells contribute to the recruitment of microglial cells in response to beta-amyloid deposition in APP/PS1 double transgenic Alzheimer mice. Neurobiol Dis 18:134-142.
55. Marr, RA, Rockenstein, E, Mukherjee, A, Kindy, MS, Hersh, LB, Gage, FH, Verma, IM, Masliah, E. (2003) Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J Neurosci 23: 1992-1996.
56. Matsuoka, Y, Saito, M, LaFrancois, J, Saito, M, Gaynor, K, Olm, V, Wangl, L, Casey, E, Lu, Y, Shiratori, C, Lemere, C, Duff, K. (2003) Novel therapeutic approach for the treatment of Alzheimer's disease by peripheral administration of agents with an affinity to β-amyloid. J Neurosci 23: 29-33.
57. McCarty, MF. (2006) Toward prevention of alzheimers disease - Potential nutraceutical strategies for suppressing the production of amyloid beta peptides. Med Hypotheses 67: 682-697.
58. Mehta, PD, Prittila, T. (2002) Biological markers of Alzheimer's disease. Drug Dev Res 56: 74-84.
59. Minamino, T, Miyauchi, H, Yoshida, T, Tateno, K, Kunieda, T, Komuro, I. (2004) Vascular cell senescence and vascular aging. J Mol Cell Cardiol 36: 175-183.
60. Mruthinti, S, Buccafusco, JJ, Hill, WD, Waller, JL, Jackson, TW, Zamrini, EY, Schade, RF. (2004) Autoimmunity in Alzheimer's disease: increased levels of circulating IgGs binding Abeta and RAGE peptides. Neurobiol Aging 25: 1023-1032.
61. Nalivaevaa, NN, Fisk, L, Kochkina, EG, Plesneva, SA, Zhuravin, IA, Babusikova, E, Dobrota, D, Turner, AJ. (2004) Effect of hypoxia/ischemia and hypoxic preconditioning/reperfusion on expression of some amyloid-degrading enzymes. Ann NY Acad Sci 1035: 21-33.
62. Nimmo, AJ, Cernak, I, Heath, DL, Hu, X, Bennett, CJ, Vink, R. (2004) Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38: 40-47.
63. Nishijima, K, Kiryu, J, Tsujikawa, A, Miyamoto, K, Honjo, M, Tanihara, H, Nonaka, A, Yamashiro, K, Katsuta, H, Miyahara, S, Honda, Y, Ogura, Y. (2004) Platelets adhering to the vascular wall mediate postischemic leukocyte-endothelial cell interactions in retinal microcirculation. Invest Ophthalmol Vis Sci 45: 977-984.
64. Niwa, K, Younkin, L, Ebeling, C, Turner, SK, Westaway, D, Younkin, S, Ashe, KH, Carlson, GA, Iadecola, C. (2000) Abeta 1-40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation. Proc Natl Acad Sci USA 97: 9735-9740.
65. Niwa, K, Porter, VA, Kazama, K, Cornfield, D, Carlsson, GA, Iadecola, C. (2001) A beta-peptides enhance vasoconstriction in cerebral circulation. Am J Physiol Heart Circ Physiol 281: H2417-H2424.
66. Ohtake, M, Morino, S, Kaidoh, T, Inoué, T. (2004) Three-dimensional structural changes in cerebral microvessels after transient focal cerebral ischemia in rats: Scanning electron microscopic study of corrosion casts. Neuropathology 24: 219-227.
67. Paris, D, Patel, N, DelleDonne, A, Quadros, A, Smeed, R, Mullan, M. (2004a) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366: 80-85.
68. Paris, D, Townsend, K, Quadros, A, Humphrey, J, Sun, J, Brem, S, Wotoczek-Obadia, M, DellaDonne, A, Patel, N, Obergon, DF, Crescentini, R, Abdullah, L, Coppola, D, Rojiani, AM, Crawford, F, Sebti, SM, Mullan, M. (2004b) Inhibition of angiogenesis by Aβ peptides. Angiogenesis 7: 75-85.
69. Petito, CK, Pulsinelli, WA, Jacobson, G, Plum, F. (1982) Edema and vascular permeability in cerebral ischemia: comparison between ischemic neuronal damage and infarction. J Neuropathol Exp Neurol 41: 423-436.
70. Pluta, R. (2000) The role of apolipoprotein E in the deposition of β-amyloid peptide during ischemia-reperfusion brain injury. A model of early Alzheimer's disease. Ann NY Acad Sci 903: 324-334.
71. Pluta, R, Misicka, A, Barcikowska, M, Spisacka, S, Lipkowski, AW, Januszewski, S. (2000) Possible reverse transport of ??-amyloid peptide across the blood-brain barrier. Acta Neurochir (Suppl) 76: 73-77.
72. Pluta, R. (2002a) Glial expression of the beta-amyloid peptide in cardiac arrest. J Neurol Sci 203-204: 277-280.
73. Pluta, R. (2002b) Astroglial expression of the beta-amyloid in ischemiareperfusion brain injury. Ann NY Acad Sci 977: 102-108.
74. Pluta, R. (2003) Blood-brain barrier dysfunction and amyloid precursor protein accumulation in microvascular compartment following ischemia-reperfusion brain injury with 1-year survival. Acta Neurochir (Suppl) 86: 117-122.
75. Pluta, R. (2004a) Alzheimer lesions after ischemia-reperfusion brain injury. Folia Neuropathol 42: 181-186.
76. Pluta, R. (2004b) From brain ischemia-reperfusion injury to possible sporadic Alzheimer's disease. Curr Neurovasc Res 1: 441-453.
77. Pluta, R. (2005) Pathological opening of the blood-brain barrier to horseradish peroxidase and amyloid precursor protein following ischemiareperfusion brain injury. Chemotherapy 51: 223-226.
78. Pluta, R. (2006) Ischemia-reperfusion factors in sporadic Alzheimer's disease. In: New research on Alzheimer's disease. Welsh, EM, Ed., Nova Science Publishers: Hauppauge, pp. 183-234.
79. Pluta, R, Ułamek, M, Januszewski, S. (2006) Micro-blood-brain barrier openings and cytotoxic fragments of amyloid precursor protein accumulation in white matter after ischemic brain injury in long-lived rats. Acta Neurochir (Suppl) 96: 267-271.
80. Pogue, AI, Lukiw, WJ. (2004) Angiogenic signaling in Alzheimer's disease. Neuroreport 15: 1507-1510.
81. Price, JM, Chi, X, Hellermann, G, Sutton, ET. (2001) Physiological levels of β-amyloid induce cerebral vessel dysfunction and reduce endothelial nitric oxide production. Neurol Res 23: 506-512.
82. Ramsauer, M, Krause, D, Dermietzel, R. (2002) Angiogenesis of the bloodbrain barrier in vitro and the function of cerebral pericytes. FASEB J 16: 1274-1276.
83. Rangan, SK, Liu, R, Brune, D, Planque, S, Paul, S, Sierks, MR. (2003) Degradation of beta-amyloid by proteolytic antibody light chains. Biochemistry 42: 14328-14334.
84. Ritter, LS, Stempel, KM, Coull, BM, McDonagh, PF. (2005) Leukocyteplatelet aggregates in rat peripheral blood after ischemic stroke and reperfusion. Biol Res Nurs 6: 281-288.
85. Sastre, M, Dewachter, I, Landreth, GE, Willson, TM, Klockgether, T, Van Leuven, F, Heneka, MT. (2003) Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-γ agonists modulate immunostimulated processing of amyloid precursor protein through regulation of β-secretase. J Neurosci 23: 9796-9804.
86. Sastre, M, Dewachter, I, Roßner, S, Bogdanovic, N, Rosen, E, Borghgraef, P, Evert, BO, Dumitrescu-Ozimek, L, Thal, DR, Landreth, G, Walter, J, Klockgether, T, van Leuven, F, Heneka, MT. (2006) Nonsteridal anti-inflammatory drugs repress β-secretase gene promotor activity by the activation of PPARγ. Proc Natl Acad Sci USA 103: 443-448.
87. Simard, AR, Soulet, D, Gowing, G, Julien, JP, Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49: 489-502.
88. Spires, TL, Hyman, BT. (2005) Transgenic models of Alzheimer's disease: learning from animals. NeuroRx 2: 423-437.
89. Stalder, AK, Ermini, F, Bondolfi, L, Krenger, W, Burbach, GJ, Deller, T, Coomaraswamy, J, Staufenbiel, M, Landmann, R, Jucker, M. (2005) Invasion of hematopoietic cells into the brain of amyloid precursor protein transgenic mice. J Neurosci 25: 11125-11132.
90. Tanzi, RE, Moir, RD, Wagner, SL. (2004) Clearance of Alzheimer's Aβ peptide: the many roads to perdition. Neuron 43: 605-608.
91. Thomas, T, Thomas, G, McLendon, C, Sutton, T, Mullan, M. (1996) β-amyloid-mediated vasoactivity and vascular endothelial damage. Nature 380: 168-171.
92. Ueno, M, Tomimoto, H, Akiguchi, I, Wakita, H, Sakamoto, H. (2002) Blood-brain barrier disruption in white matter lesions in a rat model of chronic cerebral hypoperfusion. J Cereb Blood Flow Metab 22: 97-104.
93. Ujiie, M, Dickstein, DL, Carlow, DA, Jefferies, WA. (2003) Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 10: 463-470.
94. Van Groen, T, Puurunen, K, Maki, HM, Sivenius, J, Jolkkonen, J. (2005) Transformation of diffuse beta-amyloid precursor protein and betaamyloid deposits to plaques in the thalamus after transient occlusion of the middle cerebral artery in rats. Stroke 36:1551-1556.
95. Wagner, KR, Dean, C, Beiler, S, Bryan, DW, Packard, BA, Smulian, AG, Linke, MJ, de Courten-Myers, GM. (2005) Plasma infusions into porcine cerebral white matter induce early edema, oxidative stress, proinflammatory cytokine gene expression and DNA fragmentation: Implications for white matter injury with increased blood-brain barrier permeability. Curr Neurovasc Res 2: 149-155.
96. Walter, J, Kaether, C, Steiner, H, Haass, C. (2001) The cell biology of Alzheimer's disease: uncovering the secrets of secretases. Curr Opin Neurobiol 11: 585-590.
97. Wardlow, JM, Sandercock, PA, Dennis, MS, Starr, J. (2003) Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke 34: 806-812.
98. Wen, Y, Onyewuchi, O, Yang, S, Liu, R, Simpkins, JW. (2004) Increased beta-secretase activity and expression in rats following transient cerebral ischemia. Brain Res 1009: 1-8.
99. Wisniewski, HM, Maslinska, D. (1996) Beta-protein immunoreactivity in the human brain after cardiac arrest. Folia Neuropathol 34: 65-71.
100. Wolfe, MS, Xia, W, Ostaszewski, BL, Diehl, TS, Kimberly, WT, Selkoe, DJ. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity. Nature 398: 513-517.
101. Yang, F, Lim, GP, Begum, AN, Ubeda, OJ, Simmons, MR, Ambegaokar, SS, Chen, PP, Kayed, R, Glabe, CG, Frautschy, SA, Cole, GM. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280: 5892-5901.
102. Zipser, BD, Johanson, CE, Gonzalez, L, Berzin, TM, Tavares, R, Hultte, CM, Vitek, MP, Hovanesian, V, Stopa, EG. (2006) Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging [Epub ahead of print].
103. Zlokovic, BV, Martel, CL, Matsubara, E, McComb, JG, Zhang, G, McCluskey, RT, Frangione, B, Ghiso, J. (1996) Glycoprotein 330/megalin: probable role in receptor-mediated transport of apolipoprotein J alone and in a complex with Alzheimer disease amyloid beta at the bloodbrain and blood-cerebrospinal fluid barriers. Proc Natl Acad Sci USA 93: 4229-4234.